GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (FRA:WX8) » Definitions » Institutional Ownership

Wuxi AppTec Co (FRA:WX8) Institutional Ownership : 6.34% (As of May. 21, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Wuxi AppTec Co's institutional ownership is 6.34%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Wuxi AppTec Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Wuxi AppTec Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Wuxi AppTec Co Institutional Ownership Historical Data

The historical data trend for Wuxi AppTec Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co Institutional Ownership Chart

Wuxi AppTec Co Historical Data

The historical data trend for Wuxi AppTec Co can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 6.71 7.03 8.46 8.68 8.68 7.80 7.65 6.94 6.40 6.34

Wuxi AppTec Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Wuxi AppTec Co (FRA:WX8) Business Description

Traded in Other Exchanges
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices. Its segments comprise China-based laboratory services; U.S.-based laboratory services; Clinical research and other CRO services; CDMO services; and Others. The majority of revenue gets derived from China-based laboratory services that include small molecules discovery, such as synthetic chemistry, medicinal chemistry, analytical chemistry, biology, drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME), toxicology and bioanalytical services.

Wuxi AppTec Co (FRA:WX8) Headlines

No Headlines